Hjem › Geografisk atrofi › South Carolina
Kliniske studier for Geografisk atrofi i South Carolina
4 studier for Geografisk atrofi søker deltakere på steder i South Carolina.
Offisiell studietekst (engelsk)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Charleston Neuroscience Institute, LLC, Beaufort
RekruttererFase 2/3
Alder 60 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06635148A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Charleston Neuroscience Institute - Ladson- Site Number : 8400016, Ladson
- Charleston Neuroscience Institute - Ladson- Site Number : 8400046, Ladson
RekruttererFase 1/2
Alder 60 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07215234A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Retina Consultants of Carolina, Greenville
- Charleston Neuroscience Institute LLC, Ladson
- Charleston Neuroscience Institute, LLC, Mt. Pleasant
- og 1 flere
RekruttererFase 3
Alder 50 til 85 · Alle kjønn · Oppdatert 18. sep. 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Charleston Neuroscience Institute, Mt. Pleasant
- Palmetto Retina Center, West Columbia
RekruttererFase 2
Alder 55 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT06659445Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.